Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Is Not Associated with Neurological Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage.

Kiiski, Heikki; Jalkanen, Ville; Ala-Peijari, Marika; Hämäläinen, Mari; Moilanen, Eeva; Peltola, Jukka; Tenhunen, Jyrki

Kiiski, Heikki; Jalkanen, Ville; Ala-Peijari, Marika; Hämäläinen, Mari; Moilanen, Eeva; Peltola, Jukka; Tenhunen, Jyrki.

Afiliación

Kiiski H; Critical Care Medicine Research Group, Department of Intensive Care, Tampere University Hospital, Tampere, Finland.
Jalkanen V; Critical Care Medicine Research Group, Department of Intensive Care, Tampere University Hospital, Tampere, Finland.
Ala-Peijari M; Critical Care Medicine Research Group, Department of Intensive Care, Tampere University Hospital, Tampere, Finland.
Hämäläinen M; The Immunopharmacology Research Group, Faculty of Medicine and Life Sciences, University of Tampere, Tampere University Hospital, Tampere, Finland.
Moilanen E; The Immunopharmacology Research Group, Faculty of Medicine and Life Sciences, University of Tampere, Tampere University Hospital, Tampere, Finland.
Peltola J; Department of Neurology, University of Tampere, Tampere University Hospital, Tampere, Finland.
Tenhunen J; Critical Care Medicine Research Group, Department of Intensive Care, Tampere University Hospital, Tampere, Finland.

Front Neurol ; 8: 144, 2017.

Article en En | MEDLINE | ID: mdl-28458650

Palabras clave

aneurysmal subarachnoid hemorrhage; biomarkers; neuroinflammation; neurological outcome; secondary brain injury; soluble urokinase-type plasminogen activator receptor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Año: 2017 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google